Total Payments
$5,066
2024 Payments
$1,664
Companies
22
Transactions
245
Medicare Patients
6,037
Medicare Billing
$258,951
Payment Breakdown by Category
Food & Beverage$5,063 (99.9%)
Education$2.69 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,063 | 244 | 99.9% |
| Education | $2.69 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $938.17 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $636.32 | 20 | $0 (2024) |
| Novo Nordisk Inc | $530.62 | 32 | $0 (2024) |
| BeiGene USA, Inc. | $400.00 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $382.35 | 22 | $0 (2024) |
| Amgen Inc. | $322.51 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $312.05 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $196.59 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $190.54 | 10 | $0 (2024) |
| Exact Sciences Corporation | $186.84 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,664 | 79 | AstraZeneca Pharmaceuticals LP ($374.83) |
| 2023 | $1,529 | 74 | Lilly USA, LLC ($373.84) |
| 2022 | $1,185 | 63 | Lilly USA, LLC ($286.84) |
| 2021 | $666.01 | 27 | BeiGene USA, Inc. ($125.00) |
| 2017 | $22.18 | 2 | Sunovion Pharmaceuticals Inc. ($22.18) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: DIABETES | ||||||
| 10/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.95 | General |
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.13 | General |
| Category: Cardiovascular | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,547 | 1,840 | $135,673 | $75,567 |
| 2022 | 28 | 1,427 | 1,705 | $127,962 | $71,154 |
| 2021 | 31 | 1,647 | 2,026 | $140,862 | $59,842 |
| 2020 | 30 | 1,416 | 1,741 | $128,022 | $52,389 |
Total Patients
6,037
Total Services
7,312
Medicare Billing
$258,951
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $45,750 | $23,027 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 172 | $25,972 | $15,310 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 142 | $14,200 | $8,904 | 62.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,338 | $5,926 | 80.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 15 | $4,985 | $3,092 | 62.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $3,000 | $2,877 | 95.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $4,150 | $2,392 | 57.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 125 | 143 | $4,147 | $1,876 | 45.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 131 | 147 | $3,381 | $1,521 | 45.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 69 | 78 | $2,808 | $1,284 | 45.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 80 | 128 | $2,688 | $1,219 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $1,517 | $1,210 | 79.8% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 24 | 25 | $2,175 | $1,011 | 46.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 119 | 136 | $1,904 | $862.24 | 45.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 28 | $2,100 | $812.28 | 38.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 55 | 77 | $1,309 | $638.33 | 48.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $740.00 | $590.20 | 79.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 21 | 24 | $744.00 | $354.72 | 47.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 22 | 26 | $754.00 | $347.36 | 46.1% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 22 | 25 | $850.00 | $312.50 | 36.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 14 | 14 | $672.00 | $264.88 | 39.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 69 | 85 | $680.00 | $264.35 | 38.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 32 | $544.00 | $243.52 | 44.8% |
| 82746 | Folic acid level, serum | Office | 2023 | 13 | 15 | $435.00 | $216.15 | 49.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 31 | 34 | $408.00 | $192.44 | 47.2% |
About Dr. Min Yang, MD
Dr. Min Yang, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1255574000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Min Yang, MD has received a total of $5,066 in payments from pharmaceutical and medical device companies, with $1,664 received in 2024. These payments were reported across 245 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,063).
As a Medicare-enrolled provider, Yang has provided services to 6,037 Medicare beneficiaries, totaling 7,312 services with total Medicare billing of $258,951. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 04/09/2009
- Last Updated 12/20/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255574000
Products in Payments
- JARDIANCE (Drug) $566.73
- ELIQUIS (Drug) $401.34
- BRUKINSA (Drug) $400.00
- TRULICITY (Drug) $383.86
- Otezla (Drug) $290.16
- BREZTRI (Drug) $288.08
- FARXIGA (Drug) $252.04
- Ozempic (Drug) $251.57
- Rybelsus (Drug) $223.71
- Cologuard Collection Kit (Device) $186.84
- Vascepa (Drug) $143.16
- EMGALITY (Drug) $135.08
- SHINGRIX (Biological) $127.99
- Tavalisse (Drug) $125.00
- MOUNJARO (Drug) $120.82
- STIOLTO RESPIMAT (Drug) $114.03
- Kerendia (Drug) $111.95
- BELSOMRA (Drug) $101.20
- XARELTO (Drug) $98.00
- AIRSUPRA (Drug) $96.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Family Medicine $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Family Medicine $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Family Medicine $15,123
Dr. David Pawlowski, Md, MD
Family Medicine — Payments: $14,600
Family Medicine $14,600
Dr. Stacey Gugino, Md, MD
Family Medicine — Payments: $13,585
Family Medicine $13,585
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074
Family Medicine $12,074